Mastek shares surged over 2% on Wednesday after announcing its partnership with Onyx Health. As of 11:25 am the shares of Mastek were trading 1.88% higher at ₹3,057.00 on NSE,
In today’s healthcare landscape, effective data exchange is crucial for delivering quality care. The partnership between Mastek and Onyx Health will provide health plans with a ready-made solution to meet CMS-9115 (Patient Access API) and CMS-0057 (Advancing Interoperability and Electronic Prior Auth) regulations. These rules are essential for modernizing healthcare data sharing, ensuring secure and standardized communication across different systems.
Key highlights of the partnership include:
- Enhanced Interoperability: By combining Mastek’s expertise in consulting and implementation with Onyx Health’s OnyxOS platform, the partnership will speed up the adoption of FHIR standards, facilitating seamless data exchange in healthcare.
- Compliance Solutions: The collaboration offers a comprehensive compliance solution tailored to CMS-9115 and CMS-0057 rules, helping health plans stay compliant with current regulations while streamlining their processes.
- Improved Health Outcomes: The goal is to enhance patient outcomes by providing healthcare providers with accurate and timely data, leading to better decision-making and more personalized care.
Raman Sapra, President & Chief Growth Officer at Mastek, commented, “Our partnership with Onyx simplifies healthcare mandates and compliance deadlines, improving quality ratings and patient experiences. This collaboration underscores our commitment to delivering advanced solutions in the healthcare sector.”
Susheel Ladwa, CEO at Onyx Health, added, “Working with Mastek is a major step forward in our mission to transform healthcare data exchange. Combining our OnyxOS platform with Mastek’s expertise will deliver solutions that ensure compliance and improve patient outcomes.”
